236 related articles for article (PubMed ID: 32513998)
1. Additive prognostic value of red cell distribution width over late gadolinium enhancement on CMR in patients with non-ischemic dilated cardiomyopathy.
Yi JE; Lee HJ; Kim YJ; Kim Y; Joung B; Park J
Sci Rep; 2020 Jun; 10(1):9212. PubMed ID: 32513998
[TBL] [Abstract][Full Text] [Related]
2. Feature-Tracking Global Longitudinal Strain Predicts Death in a Multicenter Population of Patients With Ischemic and Nonischemic Dilated Cardiomyopathy Incremental to Ejection Fraction and Late Gadolinium Enhancement.
Romano S; Judd RM; Kim RJ; Kim HW; Klem I; Heitner JF; Shah DJ; Jue J; White BE; Indorkar R; Shenoy C; Farzaneh-Far A
JACC Cardiovasc Imaging; 2018 Oct; 11(10):1419-1429. PubMed ID: 29361479
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of late gadolinium enhancement in cardiac MRI of non-ischemic dilated cardiomyopathy patients.
Behera DR; V K AK; K K NN; S S; Nair KKM; G S; T R K; Gopalakrishnan A; S H
Indian Heart J; 2020; 72(5):362-368. PubMed ID: 33189195
[TBL] [Abstract][Full Text] [Related]
4. The Combined Incremental Prognostic Value of LVEF, Late Gadolinium Enhancement, and Global Circumferential Strain Assessed by CMR.
Mordi I; Bezerra H; Carrick D; Tzemos N
JACC Cardiovasc Imaging; 2015 May; 8(5):540-549. PubMed ID: 25890580
[TBL] [Abstract][Full Text] [Related]
5. Does stress perfusion imaging improve the diagnostic accuracy of late gadolinium enhanced cardiac magnetic resonance for establishing the etiology of heart failure?
Gulsin GS; Shetye A; Khoo J; Swarbrick DJ; Levelt E; Lai FY; Squire IB; Arnold JR; McCann GP
BMC Cardiovasc Disord; 2017 Apr; 17(1):98. PubMed ID: 28390413
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of myocardial strain and late gadolinium enhancement on cardiovascular magnetic resonance imaging in patients with idiopathic dilated cardiomyopathy with moderate to severely reduced ejection fraction.
Pi SH; Kim SM; Choi JO; Kim EK; Chang SA; Choe YH; Lee SC; Jeon ES
J Cardiovasc Magn Reson; 2018 Jun; 20(1):36. PubMed ID: 29898740
[TBL] [Abstract][Full Text] [Related]
7. Quantifying late gadolinium enhancement on CMR provides additional prognostic information in early risk-stratification of nonischemic cardiomyopathy: a cohort study.
Pöyhönen P; Kivistö S; Holmström M; Hänninen H
BMC Cardiovasc Disord; 2014 Aug; 14():110. PubMed ID: 25160650
[TBL] [Abstract][Full Text] [Related]
8. Magnetic resonance imaging of dilated cardiomyopathy: prognostic benefit of identifying late gadolinium enhancement in Asian patients.
Infante AN; Koo CCY; Yip A; Lim YH; Yeo WT; Quek ST; Lim TW; Seow SC; Chai P; Ong CC; Teo L; Singh D; Kojodjojo P
Singapore Med J; 2021 Jul; 62(7):347-352. PubMed ID: 31820004
[TBL] [Abstract][Full Text] [Related]
9. Myocardial Fibrosis Assessment by LGE Is a Powerful Predictor of Ventricular Tachyarrhythmias in Ischemic and Nonischemic LV Dysfunction: A Meta-Analysis.
Disertori M; Rigoni M; Pace N; Casolo G; Masè M; Gonzini L; Lucci D; Nollo G; Ravelli F
JACC Cardiovasc Imaging; 2016 Sep; 9(9):1046-1055. PubMed ID: 27450871
[TBL] [Abstract][Full Text] [Related]
10. Late gadolinium enhancement on cardiac magnetic resonance predicts adverse cardiovascular outcomes in nonischemic cardiomyopathy: a systematic review and meta-analysis.
Kuruvilla S; Adenaw N; Katwal AB; Lipinski MJ; Kramer CM; Salerno M
Circ Cardiovasc Imaging; 2014 Mar; 7(2):250-258. PubMed ID: 24363358
[TBL] [Abstract][Full Text] [Related]
11. Comparing CMR Mapping Methods and Myocardial Patterns Toward Heart Failure Outcomes in Nonischemic Dilated Cardiomyopathy.
Vita T; Gräni C; Abbasi SA; Neilan TG; Rowin E; Kaneko K; Coelho-Filho O; Watanabe E; Mongeon FP; Farhad H; Rassi CH; Choi YL; Cheng K; Givertz MM; Blankstein R; Steigner M; Aghayev A; Jerosch-Herold M; Kwong RY
JACC Cardiovasc Imaging; 2019 Aug; 12(8 Pt 2):1659-1669. PubMed ID: 30448130
[TBL] [Abstract][Full Text] [Related]
12. Left ventricular long axis strain: a new prognosticator in non-ischemic dilated cardiomyopathy?
Riffel JH; Keller MG; Rost F; Arenja N; Andre F; Aus dem Siepen F; Fritz T; Ehlermann P; Taeger T; Frankenstein L; Meder B; Katus HA; Buss SJ
J Cardiovasc Magn Reson; 2016 Jun; 18(1):36. PubMed ID: 27268238
[TBL] [Abstract][Full Text] [Related]
13. A novel cardiac magnetic resonance-based personalized risk stratification model in dilated cardiomyopathy: a prospective study.
Zhou D; Zhu L; Wu W; Zhuang B; He J; Xu J; Yang W; Wang Y; Li S; Sun X; Sharma P; Liu G; Sirajuddin A; Arai A; Zhao S; Lu M
Eur Radiol; 2024 Jun; 34(6):4053-4064. PubMed ID: 37950081
[TBL] [Abstract][Full Text] [Related]
14. Complexity of scar and ventricular arrhythmias in dilated cardiomyopathy of any etiology: Long-term data from the SCARFEAR (Cardiovascular Magnetic Resonance Predictors of Appropriate Implantable Cardioverter-Defibrillator Therapy Delivery) Registry.
Pedretti S; Vargiu S; Baroni M; Dellegrottaglie S; Lanzarin B; Roghi A; Milazzo A; Quattrocchi G; Lunati M; Pedrotti P
Clin Cardiol; 2018 Apr; 41(4):494-501. PubMed ID: 29663442
[TBL] [Abstract][Full Text] [Related]
15. Prognostic implications of late gadolinium enhancement at the right ventricular insertion point in patients with non-ischemic dilated cardiomyopathy: A multicenter retrospective cohort study.
Yi JE; Park J; Lee HJ; Shin DG; Kim Y; Kim M; Kwon K; Pyun WB; Kim YJ; Joung B
PLoS One; 2018; 13(11):e0208100. PubMed ID: 30485353
[TBL] [Abstract][Full Text] [Related]
16. Implications of multiple late gadolinium enhancement lesions on the frequency of left ventricular reverse remodeling and prognosis in patients with non-ischemic cardiomyopathy.
Ota S; Orii M; Nishiguchi T; Yokoyama M; Matsushita R; Takemoto K; Tanimoto T; Hirata K; Hozumi T; Akasaka T
J Cardiovasc Magn Reson; 2021 Mar; 23(1):32. PubMed ID: 33761955
[TBL] [Abstract][Full Text] [Related]
17. The Prognostic Value of Late Gadolinium-Enhanced Cardiac Magnetic Resonance Imaging in Nonischemic Dilated Cardiomyopathy: A Review and Meta-Analysis.
Becker MAJ; Cornel JH; van de Ven PM; van Rossum AC; Allaart CP; Germans T
JACC Cardiovasc Imaging; 2018 Sep; 11(9):1274-1284. PubMed ID: 29680351
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Benefit of Cardiac Magnetic Resonance Over Transthoracic Echocardiography for the Assessment of Ischemic and Nonischemic Dilated Cardiomyopathy Patients Referred for the Evaluation of Primary Prevention Implantable Cardioverter-Defibrillator Therapy.
Pontone G; Guaricci AI; Andreini D; Solbiati A; Guglielmo M; Mushtaq S; Baggiano A; Beltrama V; Fusini L; Rota C; Segurini C; Conte E; Gripari P; Dello Russo A; Moltrasio M; Tundo F; Lombardi F; Muscogiuri G; Lorenzoni V; Tondo C; Agostoni P; Bartorelli AL; Pepi M
Circ Cardiovasc Imaging; 2016 Oct; 9(10):. PubMed ID: 27729359
[TBL] [Abstract][Full Text] [Related]
19. Pattern of late gadolinium enhancement predicts arrhythmic events in patients with non-ischemic cardiomyopathy.
Shin DG; Lee HJ; Park J; Uhm JS; Pak HN; Lee MH; Kim YJ; Joung B
Int J Cardiol; 2016 Nov; 222():9-15. PubMed ID: 27458824
[TBL] [Abstract][Full Text] [Related]
20. The extent of late gadolinium enhancement predicts mortality, sudden death and major adverse cardiovascular events in patients with nonischaemic cardiomyopathy: a systematic review and meta-analysis.
Golukhova EZ; Bulaeva NI; Alexandrova SA; Mrikaev DV; Gromova OI; Ruzina EV; Berdibekov BS
Clin Radiol; 2023 Apr; 78(4):e342-e349. PubMed ID: 36707397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
